Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining Stereotactic Radiotherapy and Conventional Radiotherapy for Peripheral Locally Advanced Lung Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

[Primary spontaneous pneumothorax: We have time to get some fresh air…].

Revue des maladies respiratoires·2023
Same author

[French practical guidelines for the diagnosis and management of IPF - 2021 update, full version].

Revue des maladies respiratoires·2022
Same author

[French practical guidelines for the diagnosis and management of IPF - 2021 update, short version].

Revue des maladies respiratoires·2022
Same author

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.

ESMO open·2021
Same author

Exuberant cystic destruction of lung parenchyma.

Respiratory medicine and research·2020

Related Experiment Video

Updated: May 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Bronchoscopic treatments for emphysema.

A Delage1, C-H Marquette

  • 1Service de Pneumologie, Oncologie Thoracique et Soins Intensifs Respiratoires, Hôpital Pasteur, CHU de Nice, pavillon H, 30, avenue de la Voie-Romaine, BP 1069, 06002 Nice cedex 1, France.

Revue Des Maladies Respiratoires
|November 22, 2011
PubMed
Summary
This summary is machine-generated.

Identifying predictors of response to lung volume reduction therapy is crucial for advanced emphysema patients. This research seeks to find factors that indicate success with less invasive emphysema treatments.

More Related Videos

Robotic-assisted Bronchoscopy Combined with Multimodal Imaging for Targeted Lung Cryobiopsies
04:10

Robotic-assisted Bronchoscopy Combined with Multimodal Imaging for Targeted Lung Cryobiopsies

Published on: July 19, 2024

Related Experiment Videos

Last Updated: May 27, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Robotic-assisted Bronchoscopy Combined with Multimodal Imaging for Targeted Lung Cryobiopsies
04:10

Robotic-assisted Bronchoscopy Combined with Multimodal Imaging for Targeted Lung Cryobiopsies

Published on: July 19, 2024

Area of Science:

  • Pulmonology
  • Thoracic Surgery
  • Biomedical Engineering

Background:

  • Advanced emphysema in chronic obstructive pulmonary disease (COPD) exacerbates respiratory symptoms through impaired gas exchange and altered respiratory mechanics like hyperinflation.
  • Lung volume reduction surgery (LVRS) improves outcomes but has high morbidity and cost.
  • Current alternatives to LVRS focus on reducing lung volume or redistributing airflow using devices, showing safety and modest benefits.

Purpose of the Study:

  • To identify predictors of therapeutic response in patients with advanced emphysema undergoing lung volume reduction therapies.
  • To evaluate the effectiveness of novel, less invasive devices compared to traditional LVRS.

Main Methods:

  • Review of preliminary studies on devices for lung volume reduction (endobronchial valves, plugs, parenchymal injection agents, airway bypass systems).
  • Analysis of patient data to correlate baseline characteristics with treatment outcomes.
  • Assessment of safety and efficacy, including exercise capacity improvements.

Main Results:

  • Preliminary studies indicate that lung volume reduction devices are relatively safe.
  • These devices demonstrate modest benefits in exercise capacity, with potential for significant individual improvement.
  • Further investigation is needed to pinpoint specific patient factors predicting successful outcomes.

Conclusions:

  • Non-surgical lung volume reduction devices offer a safer alternative to LVRS for advanced emphysema.
  • Identifying predictors of response is essential for optimizing patient selection and maximizing therapeutic benefits.
  • Future research should focus on personalized medicine approaches for emphysema treatment.